Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Propofol for Atrial Fibrillation Ablation Sedation
NCT03844841Phase 4Completed
- Sponsor
- Insel Gruppe
- Start
- Jul 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexmedetomidine in Atrial fibrillation (AFib), sponsored by Insel Gruppe. Primary endpoint: Combined Incidence of Sedation-Emergent Adverse Events at 24 hours. Started Jul 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03844841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03844841.